Psychiatric Times October 15, 2024
Steven E. Hyler, MD

Learn more about how AI can transform mental health care.

CHATBOT CORNER

The pharmaceutical industry is in the midst of a transformative revolution driven by advancements in large language models (LLMs), generative artificial intelligence (AI), and chatbots. These technologies offer unprecedented opportunities to enhance clinical trials, streamline the dissemination of pharmaceutical information, and accelerate drug discovery.1 In this manuscript, we explore how AI is being utilized to improve efficiency, ensure better patient outcomes, and revolutionize communication strategies in the pharmaceutical landscape. Furthermore, we delve into the current challenges and opportunities of AI integration and highlight significant AI investments in the industry.

Enhancing Clinical Trials with Generative AI

Clinical trials are the backbone of pharmaceutical research, providing the evidence needed to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Clinical Trials, Mental Health, Pharma, Pharma / Biotech, Provider, Technology, Trends
Related Articles:
Microsoft’s AI Healthcare Push Aims to Boost Efficiency, Enhance Patient Care
Arm touts growing ecosystem of sustainable AI datacenter silicon
ServiceNow BrandVoice: 5 Traits Of AI Pacesetters To Help You Pull Ahead
Driving Real Business Value With Generative AI For SMBs And Beyond
The one question you need to ask ChatGPT right now

Share This Article